Denis Moro-Sibilot - JoVE Visualize

Showing results (141-150 of 155) with videos related to

Pageof 16

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancerAlain Depierre, Bernard Milleron, Denis Moro-Sibilot, et al.

The New England Journal of Medicine|May 29, 2026

First-Line Sunvozertinib in NSCLC with <i>EGFR</i> Exon 20 Insertion MutationsCaicun Zhou, Laurent Greillier, Geoffrey Liu, et al.

Frontiers in Immunology|March 20, 2026

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patientsSeverine Planel, Guillaume Vayssière, Gianni Maggipinto, et al.

Oncoimmunology|April 7, 2025

Surrogate markers of intestinal dysfunction associated with survival in advanced cancersRoxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.

Clinical Lung Cancer|July 2, 2020

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer PatientsElisa Gobbini, Anne Claire Toffart, Maurice Pérol, et al.

Bulletin Du Cancer|November 21, 2002

[2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer]Jeanne-Marie Bréchot, Thierry Molina, Serge Theobald, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022

Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 TrialFabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.

The New England Journal of Medicine|January 10, 2024

Repotrectinib in <i>ROS1</i> Fusion-Positive Non-Small-Cell Lung CancerAlexander Drilon, D Ross Camidge, Jessica J Lin, et al.

Bulletin Du Cancer|March 28, 2003

[Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients]Alain Depierre, Jean-Léon Lagrange, Serge Theobald, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021

Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryAlexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.

Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:

Pageof 16

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancerAlain Depierre, Bernard Milleron, Denis Moro-Sibilot, et al.

The New England Journal of Medicine|May 29, 2026

First-Line Sunvozertinib in NSCLC with <i>EGFR</i> Exon 20 Insertion MutationsCaicun Zhou, Laurent Greillier, Geoffrey Liu, et al.

Frontiers in Immunology|March 20, 2026

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patientsSeverine Planel, Guillaume Vayssière, Gianni Maggipinto, et al.

Oncoimmunology|April 7, 2025

Surrogate markers of intestinal dysfunction associated with survival in advanced cancersRoxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.

Clinical Lung Cancer|July 2, 2020

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer PatientsElisa Gobbini, Anne Claire Toffart, Maurice Pérol, et al.

Bulletin Du Cancer|November 21, 2002

[2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer]Jeanne-Marie Bréchot, Thierry Molina, Serge Theobald, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022

Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 TrialFabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.

The New England Journal of Medicine|January 10, 2024

Repotrectinib in <i>ROS1</i> Fusion-Positive Non-Small-Cell Lung CancerAlexander Drilon, D Ross Camidge, Jessica J Lin, et al.

Bulletin Du Cancer|March 28, 2003

[Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients]Alain Depierre, Jean-Léon Lagrange, Serge Theobald, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021

Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryAlexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.

Pageof 16